Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 43.59B | 44.07B | 42.10B | 41.55B | 38.95B | 35.87B |
Gross Profit | 8.49B | 8.70B | 7.42B | 7.19B | 7.40B | 6.69B |
EBITDA | 3.68B | 3.63B | 3.16B | 2.51B | 3.08B | 2.80B |
Net Income | 1.43B | 1.32B | 847.54M | 519.89M | 960.51M | 925.19M |
Balance Sheet | ||||||
Total Assets | 59.99B | 61.09B | 59.97B | 57.63B | 54.19B | 52.13B |
Cash, Cash Equivalents and Short-Term Investments | 4.72B | 4.30B | 5.08B | 4.06B | 3.99B | 2.92B |
Total Debt | 21.80B | 19.85B | 20.07B | 20.68B | 19.60B | 19.61B |
Total Liabilities | 36.64B | 34.49B | 35.30B | 34.41B | 32.59B | 31.49B |
Stockholders Equity | 23.00B | 26.59B | 24.39B | 22.91B | 21.27B | 20.30B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 120.16M | 1.90B | -792.30M | 901.36M | 487.76M |
Operating Cash Flow | 0.00 | 1.26B | 3.03B | 574.79M | 2.34B | 1.88B |
Investing Cash Flow | 0.00 | -1.14B | -1.45B | -438.45M | -1.57B | -1.30B |
Financing Cash Flow | 0.00 | -534.05M | -1.09B | 439.57M | -261.57M | -1.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥7.31B | 5.49 | 3.48% | 4.68% | 55.21% | ||
76 Outperform | ¥2.62B | 5.70 | 2.29% | 1.84% | 75.79% | ||
74 Outperform | ¥3.18B | 5.88 | 2.70% | 2.92% | -6.49% | ||
74 Outperform | ¥3.51B | 8.89 | 1.82% | -7.15% | 39.05% | ||
70 Outperform | ¥3.07B | 12.26 | 3.75% | -3.40% | -79.66% | ||
65 Neutral | $10.82B | 15.59 | 5.20% | 1.89% | 3.09% | -26.84% | |
60 Neutral | ¥4.12B | 58.38 | 3.72% | 0.38% | 24.47% |